Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase – Time to Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares saw an uptick in trading volume on Friday . 15,469 shares changed hands during mid-day trading, an increase of 72% from the previous session’s volume of 8,984 shares.The stock last traded at $17.02 and had previously closed at $16.00.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. UBS Group assumed coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They set a “buy” rating and a $21.00 target price on the stock. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 4.9 %

The company has a 50-day moving average price of $15.64.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.